Roger LeBlanc

1.8k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Roger LeBlanc is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Roger LeBlanc has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 20 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Roger LeBlanc's work include HIV Research and Treatment (24 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (12 papers). Roger LeBlanc is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (12 papers). Roger LeBlanc collaborates with scholars based in Canada, United States and France. Roger LeBlanc's co-authors include Jean‐Pierre Routy, Danielle Rouleau, Cécile Tremblay, Réjean Thomas, Mark A. Wainberg, Bluma Brenner, Julie Bruneau, Jean‐Guy Baril, Michel Roger and Daniela Moïsi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Roger LeBlanc

31 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection

2007 501 citations Bluma Brenner, Michel Roger et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger LeBlanc Canada	16	917	908	403	225	149	31	1.3k
Marcelo Losso Argentina	22	995 1.1×	684 0.8×	422 1.0×	127 0.6×	253 1.7×	62	1.4k
Jean-Louis Sankalé United States	20	752 0.8×	802 0.9×	297 0.7×	122 0.5×	114 0.8×	29	1.1k
Henriëtte J. Scherpbier Netherlands	23	1.1k 1.2×	1.2k 1.3×	405 1.0×	331 1.5×	393 2.6×	53	1.8k
Kamal Mansinho Portugal	18	757 0.8×	550 0.6×	431 1.1×	118 0.5×	83 0.6×	82	1.2k
Roel A. Coutinho Netherlands	19	627 0.7×	616 0.7×	540 1.3×	207 0.9×	84 0.6×	27	1.1k
Giuseppina Liuzzi Italy	18	837 0.9×	564 0.6×	331 0.8×	56 0.2×	155 1.0×	57	1.3k
Anne Willoughby United States	14	667 0.7×	527 0.6×	368 0.9×	210 0.9×	157 1.1×	20	1.1k
Richard Pilon Canada	17	662 0.7×	647 0.7×	400 1.0×	104 0.5×	72 0.5×	39	1.0k
Gabriel M. Ortiz United States	17	661 0.7×	908 1.0×	160 0.4×	363 1.6×	89 0.6×	23	1.2k
Silvia Nozza Italy	19	679 0.7×	724 0.8×	469 1.2×	255 1.1×	284 1.9×	148	1.3k

Countries citing papers authored by Roger LeBlanc

Since Specialization

Citations

This map shows the geographic impact of Roger LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger LeBlanc more than expected).

Fields of papers citing papers by Roger LeBlanc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger LeBlanc. The network helps show where Roger LeBlanc may publish in the future.

Co-authorship network of co-authors of Roger LeBlanc

This figure shows the co-authorship network connecting the top 25 collaborators of Roger LeBlanc. A scholar is included among the top collaborators of Roger LeBlanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger LeBlanc. Roger LeBlanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Brenner, Bluma, Ruxandra-Ilinca Ibanescu, Nathan Osman, et al.. (2021). The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020). Viruses. 13(8). 1643–1643. 13 indexed citations

2.

Routy, Jean‐Pierre, Cécile Tremblay, Réjean Thomas, et al.. (2020). Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers. Frontiers in Immunology. 11. 583820–583820. 7 indexed citations

3.

Mehraj, Vikram, Rayoun Ramendra, Stéphane Isnard, et al.. (2019). CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection. Frontiers in Immunology. 10. 289–289. 41 indexed citations

4.

Kiani, Zahra, Julie Bruneau, Réjean Thomas, et al.. (2017). HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 12(9). e0185160–e0185160. 18 indexed citations

5.

Mehraj, Vikram, Mohammad‐Ali Jenabian, Rosalie Ponte, et al.. (2016). The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection. AIDS. 30(10). 1617–1627. 30 indexed citations

6.

Mehraj, Vikram, Wei Cao, Rosalie Ponte, et al.. (2016). Clinical and socio-demographic characteristics and early ART initiation during primary HIV infection. Journal of Virus Eradication. 2. 9–9. 1 indexed citations

7.

Jenabian, Mohammad-Ali, Mohamed El‐Far, Kishanda Vyboh, et al.. (2015). Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. The Journal of Infectious Diseases. 212(3). 355–366. 105 indexed citations

8.

Cao, Wei, Vikram Mehraj, Benoît Trottier, et al.. (2015). Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts. Clinical Infectious Diseases. 62(2). 250–257. 54 indexed citations

9.

Recordon-Pinson, Patrícia, Gwendaline Guidicelli, Pantxika Bellecave, et al.. (2014). Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study. PLoS ONE. 9(6). e100452–e100452. 5 indexed citations

10.

Parsons, Matthew S., Jean‐Pierre Routy, Danielle Rouleau, et al.. (2013). Antibody Responses to Human Immunodeficiency Virus Envelope from Infections with Multiple Subtypes Utilize the 1F7-Idiotypic Repertoire. AIDS Research and Human Retroviruses. 29(5). 1 indexed citations

11.

Parsons, Matthew S., Danielle Rouleau, Jean‐Pierre Routy, et al.. (2011). Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire. AIDS. 25(10). 1249–1264. 8 indexed citations

12.

Kamya, Philomena, Salix Boulet, Yoav Peretz, et al.. (2010). Changes in Function of HIV-Specific T-Cell Responses with Increasing Time from Infection. Viral Immunology. 23(2). 159–168. 5 indexed citations

13.

Brenner, Bluma, Michel Roger, Jean‐Pierre Routy, et al.. (2007). High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection. The Journal of Infectious Diseases. 195(7). 951–959. 501 indexed citations breakdown →

14.

Baril, Jean-Guy, Roger LeBlanc, François Laplante, et al.. (2005). HIV‐associated Lipodystrophy Syndrome: A Review of Clinical Aspects. Canadian Journal of Infectious Diseases and Medical Microbiology. 16(4). 233–243. 51 indexed citations

15.

LeBlanc, Roger, et al.. (2004). Proteomics. Journal of Environmental Pathology Toxicology and Oncology. 23(3). 161–178. 6 indexed citations

16.

Alter, Galit, George Hatzakis, Christos Tsoukas, et al.. (2003). Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection. The Journal of Immunology. 171(1). 477–488. 41 indexed citations

17.

Alter, Galit, Danielle Rouleau, Roger LeBlanc, et al.. (2002). Human Immunodeficiency Virus (HIV)–Specific Effector CD8 T Cell Activity in Patients with Primary HIV Infection. The Journal of Infectious Diseases. 185(6). 755–765. 26 indexed citations

18.

Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 23 indexed citations

19.

Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 16 indexed citations

20.

Salomón, Horacio, Mark A. Wainberg, Bluma Brenner, et al.. (2000). Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS. 14(2). F17–F23. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact